Rethinking emergency department revisits in critically ill adults: the role of high-flow nasal oxygen
Published
October 22, 2023
Paper ID
PAP-000184
Status
Published
DOI
10.65712/tmj.test000442
Advance Services
Abstract
Background: The cost of emergency department revisits to health systems is substantial. Methods: We conducted a case series across 13 centres between 2020 and 2021. Results: Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.56 (95% CI 0.25 to 0.86). Conclusion: Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.
Introduction
emergency department revisits remains a leading cause of avoidable harm among critically ill adults.
Earlier studies of high-flow nasal oxygen were small or single-centre. Practice around high-flow nasal oxygen varies widely between centres.
Earlier studies of high-flow nasal oxygen were small or single-centre. emergency department revisits remains a leading cause of avoidable harm among critically ill adults. Guidelines make only a weak recommendation on high-flow nasal oxygen.
Materials and Methods
The primary outcome was emergency department revisits, assessed blind to allocation.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.
Results
Effects were consistent across prespecified subgroups.
The adjusted odds ratio was 0.42 (95% CI 0.40 to 0.91). emergency department revisits occurred in 21% of the intervention group versus 34% of controls. The adjusted odds ratio was 0.71 (95% CI 0.40 to 0.60).
Serious adverse events were rare and similar between groups. emergency department revisits occurred in 18% of the intervention group versus 20% of controls.
| Group | n | Events | Rate % |
|---|---|---|---|
| Age ≥ 65 | 801 | 37 | 10.5 |
| Age < 65 | 578 | 91 | 40.5 |
| Intervention | 37 | 30 | 28.6 |
Values are n (%) unless stated otherwise.

Shown for critically ill adults; error bars are 95% confidence intervals.

Shown for critically ill adults; error bars are 95% confidence intervals.
emergency department revisits occurred in 18% of the intervention group versus 35% of controls. The adjusted odds ratio was 0.84 (95% CI 0.44 to 0.89).
Serious adverse events were rare and similar between groups. emergency department revisits occurred in 4% of the intervention group versus 20% of controls.
Discussion
Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. These findings suggest that high-flow nasal oxygen is associated with better emergency department revisits in critically ill adults. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Implementation will depend on staffing, cost and local protocols. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.
Conclusions
High-flow nasal oxygen merits wider use for critically ill adults to improve emergency department revisits.
References
1. Costa N, Silva W, et al. Pharmacist-led medication review and surgical site infection. JAMA. 2011;316(3):658-1708.
2. Patel O, Herrera D, et al. Frailty screening and falls. Ann Intern Med. 2014;181(5):865-1734.
3. Nasser O, Volkov J, et al. Nurse-led discharge planning and glycaemic control. Eur Heart J. 2024;343(8):164-1320.
4. Moreau G, Rahman L, et al. Prone positioning and in-hospital mortality. Crit Care Med. 2025;183(10):83-1306.
5. Farouk H, Yilmaz F, et al. SGLT2 inhibitors and medication adherence. Crit Care Med. 2011;254(11):493-1091.
6. Yilmaz L, Farouk I, et al. A sepsis alert system and ventilator-free days. BMJ. 2022;247(1):133-1102.
7. Mensah K, Nakamura B, et al. Tranexamic acid and patient satisfaction. N Engl J Med. 2020;182(7):431-1445.
Appendices
The statistical analysis plan is in the online supplement.